RESOLUTION PUBLIC AFFAIRS, LLC

Lobbying for PFIZER · Rx Drug Manufacturer

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.